absence of uniform country-specific donor deferral criteria. While it is perfectly legal to collect blood from a person who is hypertensive (blood pressure [BP] 160/100 mm Hg) it is illegal to collect blood from a person whose BP is 120/80 but on antihypertensive medication in some countries.
While blood donation is accepted from diabetics on oral medication, diabetics controlled with insulin are to be deferred in India. This is a remnant of the colonial era when insulin was manufactured from animals and insulin was administered using syringes that were sterilized by boiling. Today, nearly all human insulin is prepared in the laboratory by genetic engineering, and all of it is given by disposable syringes making insulin as safe as any other drug. Donors on medication are often deferred in the absence of clear-cut guidelines and many a time due to our ignorance. Many blood centers defer donors during menstruation. Who are we to tell a woman what to do and what not to do during this time? Are such deferrals backed by science? Certainly not, the Australian Red Cross supports blood donations from women during this time. Many donors are on various drugs, not all of which are reasons for deferral. Further, surveys have shown donor dissatisfaction with the duration of the donation process and repetitive questioning. While our questionnaires are not as exhaustive as that in the West; it is important to critically analyze every component of the donor questionnaire and keep it simple. Abbreviated questionnaires have been shown to increase donor satisfaction without compromising on donor and patient safety. [5] In this issue, better BDM is discussed more fully in the manuscript "Social marketing of blood donation."
Better Donor BlooD ManageMent
DBM is different from better management of blood donors which we are all familiar with. Blood is a limited resource, and we have a responsibility as a health-care provider to optimize the use of a resource that is difficult to get and only available through altruistic donations. There are a number of scenarios in which blood can be better managed. Findings answer to these questions will certainly lead to better DBM.
• Is autotransfusion an option in this patient? • Are there other alternatives to transfusion in this patient so that the available donor blood can be better managed? • How do we ensure complete utilization of blood collected? • What are the reasons for high whole blood usage in developing countries? • How do we ensure there is blood readily available for a road traffic accident victim or a patient with postpartum hemorrhage? • How do we ensure that after 50 ml of blood is removed from an adult pack the remaining unit does not go waste? • How can we ensure that the recipient who receives the remaining nonconforming unit is not harmed? • How do we ensure that thawed plasma is not wasted?
What Money Cannot Buy?
There are many things that money cannot buy. Money can buy a bed, but not sleep; money can buy medicines, but not health; money can buy a house, but not happiness. Money cannot buy manners, morals, intelligence, or class. Likewise, money cannot buy human organs or blood even if they are sold with consent as the circumstances that lead to the consent for sale are not fair. Inequality, poverty, and misery are the driving forces behind such an "informed consent" that allows a person to part with his organs or blood for money and not altruism or the desire to help fellow human beings. However, we will save this discussion on what money can or cannot buy for another day and look at alternative ways of improving our blood stocks without necessarily increasing our donor database.
Quest for safe blood
Quest for safe blood is work in progress. We have progressed from blood screening to better donor management to better blood management. In this issue, I wish to make a distinction between better blood donor management (BDM) and better donor blood management (DBM). Better DBM, as opposed to better BDM, focuses on better utilization of available donor blood rather than increasing donor pool size which is an entirely different topic. In contrast, better DBM involves finding ways and means of ensuring that the available blood is used for maximum good. A newer concept patient blood management (PBM) [1] is an evidence-based, patient-centric, multidisciplinary approach aiming to optimize the care of patients who might need a transfusion and consequently the use of blood products is discussed more fully in the guest editorial of this issue.
Better BlooD Donor ManageMent
Better BDM refers to ways and means of recruiting voluntary nonremunerated donors who are becoming scarcer due to a variety of reasons in many countries. The blood supply has always been scarce. In recent years, some countries have experienced serious blood shortages following 9/11 and in others like the UK, the potential transmission risk of prion disease has brought down blood donation. [2, 3] Closer to home in the Asian countries, emerging infections such as dengue and chikungunya are having an impact on donor deferral and reducing our donor pool. In most countries, blood donors with dengue are deferred for a period of 6 months or longer, if they have received blood transfusions. Blood donors who donate regularly will be particularly affected, including apheresis donors who donate often leading to further shrinkage of the donor pool. [4] standardizing donor deferral Blood bankers around the world have embarked on better BDM techniques to recruit new donors, retain existing donors and improve blood donation rates and overcome donor shortages. However, a significant number of donors are lost due to the
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• How do we prevent wastage of blood in the operation theaters and wards? • Why is pooled platelet concentrate not being promoted as an effective alternative to single donor apheresis platelets? • Why is it that modified whole blood (whole blood without platelets or cryoprecipitate) and reconstituted whole blood (red cells suspended in plasma) find no place in the drugs and cosmetic act of India, and why is it not offered as a substitute to whole blood seekers? Most countries in the developing world have country-specific guidelines for safe donor and safe blood but no guidelines for safe transfusions. Most countries in Asian region do not have national guidelines for clinical use of blood components; hemovigilance is at its infancy and working groups to carve out guidelines for our region are virtually absent.
hoW Do We ensure Better Donor BlooD ManageMent? reducing wastage
First and foremost, we must focus on reducing our wastage. Blood wastage may occur for a number of reasons, including time expiry, transfusion transmissible infections reactivity, hemolysis, lipemia, leakage, breakage, occuring during processing, storage, and transport. Blood is often ordered but not used. A study of blood wastage at a public hospital in Guyana has shown wastage to be as high as 25%. [6] This scenario is quite common in many Asian countries too. Either platelet is prepared in large quantities and get wasted or not prepared at all for fear of wastage which again amounts to improper DBM. Likewise, there is a dearth of good quality plasma that can be used for plasma fractionation as majority of blood continues to be used as whole blood in many countries. Another study from Iran [7] has shown the average wastage rate of blood in hospitals was as high as 9.8%. Of this, time expiry accounted for 77.9% of red cell wastage. Blood inventory management entails maintaining a delicate balance between guaranteeing blood availability and minimizing wastage.
improved information technology systems for better blood utilization
Good use of information technology (IT) software can help in better understanding of blood wastage and their reasons. The effect on component wastage after enhancing the clinician's ability to order blood products only when needed and only after the patient is prepared for transfusion using a computerized physician order entry system was investigated in a multihospital network and has been shown to reduce wastage. [8] We need IT systems that facilitate capturing aliquots/nonconforming units, their acceptance for release or disposal. IT systems help in capturing data on units returned by wards, and whether the same can be returned to inventory.
enhancing shelf life
On one hand, we have a shortage and on another hand, we have time expiry as the leading cause of blood wastage accounting for more than 50% of wastage. [9] Should we then not explore ways and means of prolonging shelf life or at least using the available additive solutions for red cells and platelets? Should it not be mandatory to use additive solutions so that wastage due to time expiry can be significantly brought down?
increasing component usage
Whole blood continues to be the most widely used blood product in many developing countries although it is nonexistent in the developed world. Whole blood is a source of red cells, and this leads to wastage of other components such as plasma and platelets. First, we in Asia and other developing countries should develop a zero tolerance for whole blood except in special situations and work toward 100% components. standardizing blood units "All humans are born equal" but grow up to have different hemoglobin (Hb) levels. Dissimilarities in the donor Hb have been shown to cause nearly 100% variations in the Hb content of the red blood cell units. Labeling donor units with Hb content will lead to standardization of red cell units and could help to reduce blood transfusions, at least in those cases where donor units have more than adequate Hb. This total Hb content can be predicted fairly accurately from the donor's predonation Hb level. [10] 
measures to balance inventory and avoid wastage
A study [11] conducted to identify and analyze various factors of wastage, which can provide insight into ideal inventory management has shown that division of inventory into two parts, enlistment of soon to outdate blood components, and reduction of holding of blood units to minimum period for elective surgery patients are simple measures, which can minimize wastage and thereby help in better DBM.
improved processing, storage, and transport
For improved blood management, blood centers need to focus on improving the processes around ordering, transporting, and storing blood; simple things like using a temperature controlled device when more than one unit of blood is ordered will prevent wastage. Making a particular staff member responsible for returning the unused blood is an option. Tracking wastage on a periodic basis both at the blood bank level and ward level will also help to review usage and bring down wastage. Lack of coordination within the blood transfusion services leads to suboptimal DBM. The use of whole blood in large quantities is another crime that we continue to commit
ConClusion
Blood (and other organs) is perhaps the most important commodity that money cannot buy. We need to be proactive in managing the available blood better which we many called better DBM. First, we need to stop the extensive use of whole blood which is a crime against humanity and injustice to altruistic donors. We need to work toward 100% components. To complement this, we need ways and means of reducing wastage and enhancing shelf life like mandatory use of additive solutions. We need better IT systems to support data capturing, related to ward level wastage, better utilization of nonconforming units, and better utilization of aliquots. We also need newer products like pooled platelet concentrates and modified whole blood. However, more than this, what we need is a scientific body on the lines of BCSH to chalk out guidelines for better DBM and better PBM. The Asian Association of Transfusion Medicine can spearhead this movement for implementing better DBM described above and for improved PBM described in the guest editorial.
